Messinis I E, Nillius S J
Acta Obstet Gynecol Scand. 1982;61(4):377-9.
The effectiveness of tamoxifen and clomiphene in inducing ovulation was compared in 46 women with anovulatory infertility. All the women were given both the drugs in an alternate way. If one cycle was treated by tamoxifen the next was treated by clomiphene and vice versa. Forty-one out of the 46 women (89.1%) ovulated at least once during the study. Similar ovulation rates were achieved by tamoxifen (56.2%) and clomiphene (62.9%). The lengths of the ovulatory cycles and their luteal phases and the mid-luteal phase serum progesterone levels did not differ significantly between the two compounds. Nor did the occurrence of luteal phase defects during the tamoxifen and clomiphene treatment cycles differ. Thirty-seven of the 46 women (80.4%) responded similarly to both drugs. Thus, tamoxifen is just as effective as clomiphene in inducing ovulation in women with anovulation.
在46例无排卵性不孕症女性中比较了他莫昔芬和克罗米芬诱导排卵的有效性。所有女性均交替使用这两种药物。如果一个周期用他莫昔芬治疗,下一个周期则用克罗米芬治疗,反之亦然。46名女性中有41名(89.1%)在研究期间至少排卵一次。他莫昔芬(56.2%)和克罗米芬(62.9%)的排卵率相似。两种药物的排卵周期长度、黄体期长度以及黄体中期血清孕酮水平均无显著差异。他莫昔芬和克罗米芬治疗周期中黄体期缺陷的发生率也没有差异。46名女性中有37名(80.4%)对两种药物的反应相似。因此,在诱导无排卵女性排卵方面,他莫昔芬与克罗米芬同样有效。